- Title
- P2.44: An Update of a Pooled Analysis of Nivolumab for the Treatment of Advanced NSCLC and the Role of PD-L1 as a BIOMARKER: Track: Immunotherapy
- Creators
- Pedro Aguiar - Universidade Federal de São PauloRamon De Mello - University of AlgarveIlka Santoro - Universidade Federal de São PauloHakaru Tadokoro - Universidade Federal de São PauloCarmelia Barreto - Universidade Federal de São Paulo, São Paulo/BRAZILPedro Oliveira - Universidade do PortoGilberto Lopes - Oncoclinicas do Brasil, São Paulo/BRAZIL
- Publication Details
- Journal of thoracic oncology, Vol.11(10), pp.S245-S245
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 27676578
- Record Identifier
- 991031713786802976
Journal article
P2.44: An Update of a Pooled Analysis of Nivolumab for the Treatment of Advanced NSCLC and the Role of PD-L1 as a BIOMARKER: Track: Immunotherapy
Journal of thoracic oncology, Vol.11(10), pp.S245-S245
2016-10
PMID: 27676578
Metrics
1 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.6 Immunology
- 1.6.214 PD-1
- Web Of Science research areas
- Oncology
- Respiratory System
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites